These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1187246)

  • 1. Glucose production in the newborn dog. I. Effects of glucagon in vivo.
    Adam PA; Glazer G; Rogoff F
    Pediatr Res; 1975 Nov; 9(11):816-20. PubMed ID: 1187246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucose production in the newborn dog. II. Evaluation of autonomic and enzymatic control in the isolated perfused canine liver.
    Chilebowski RT; Adam PA
    Pediatr Res; 1975 Nov; 9(11):821-8. PubMed ID: 171617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of hepatic glucose output by glucagon and insulin in the intact dog.
    Cherrington AD; Chiasson JL; Liljenquist JE; Lacy WW; Park CR
    Biochem Soc Symp; 1978; (43):31-45. PubMed ID: 373768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of glucagon on glucose production during insulin deficiency in the dog.
    Cherrington AD; Lacy WW; Chiasson JL
    J Clin Invest; 1978 Sep; 62(3):664-77. PubMed ID: 690190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of glycogenolysis enhances gluconeogenic precursor uptake by the liver of conscious dogs.
    Shiota M; Jackson PA; Bischoff H; McCaleb M; Scott M; Monohan M; Neal DW; Cherrington AD
    Am J Physiol; 1997 Nov; 273(5):E868-79. PubMed ID: 9374671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of acute glucagon removal on the metabolic response to stress hormone infusion in the conscious dog.
    McGuinness OP; Murrell S; Moran C; Bracy D; Cherrington AD
    Metabolism; 1994 Oct; 43(10):1310-7. PubMed ID: 7934986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of 3H and 14C doubly labeled glucose and amino acids in the study of hormonal regulation of gluconeogenesis in rats.
    Dunn A; Chenoweth M; Bever K
    Fed Proc; 1977 Feb; 36(2):245-52. PubMed ID: 190046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Similar dose responsiveness of hepatic glycogenolysis and gluconeogenesis to glucagon in vivo.
    Stevenson RW; Steiner KE; Davis MA; Hendrick GK; Williams PE; Lacy WW; Brown L; Donahue P; Lacy DB; Cherrington AD
    Diabetes; 1987 Mar; 36(3):382-9. PubMed ID: 2879758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic glycogen in humans. II. Gluconeogenetic formation after oral and intravenous glucose.
    Radziuk J
    Am J Physiol; 1989 Aug; 257(2 Pt 1):E158-69. PubMed ID: 2669512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of epinephrine on glycogenolysis and gluconeogenesis in conscious overnight-fasted dogs.
    Cherrington AD; Fuchs H; Stevenson RW; Williams PE; Alberti KG; Steiner KE
    Am J Physiol; 1984 Aug; 247(2 Pt 1):E137-44. PubMed ID: 6380303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of gluconeogenesis by insulin and glucagon in the neonatal bovine.
    Donkin SS; Armentano LE
    Am J Physiol; 1994 Apr; 266(4 Pt 2):R1229-37. PubMed ID: 8184966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-related effects of epinephrine on glucose production in conscious dogs.
    Stevenson RW; Steiner KE; Connolly CC; Fuchs H; Alberti KG; Williams PE; Cherrington AD
    Am J Physiol; 1991 Mar; 260(3 Pt 1):E363-70. PubMed ID: 2003590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of quinolinic acid and glucagon on gluconeogenesis in the perfused rat liver.
    de Sagarra MR; Hochuli R; Piquerez R; Anabitarte M; Walter P
    Rev Esp Fisiol; 1978 Jun; 34(2):177-86. PubMed ID: 694206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel glucagon receptor antagonist, NNC 25-0926, blunts hepatic glucose production in the conscious dog.
    Rivera N; Everett-Grueter CA; Edgerton DS; Rodewald T; Neal DW; Nishimura E; Larsen MO; Jacobsen LO; Kristensen K; Brand CL; Cherrington AD
    J Pharmacol Exp Ther; 2007 May; 321(2):743-52. PubMed ID: 17308040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type 2 diabetic patients have increased gluconeogenic efficiency to substrate availability, but intact autoregulation of endogenous glucose production.
    Toft I; Jenssen T
    Scand J Clin Lab Invest; 2005; 65(4):307-20. PubMed ID: 16076686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential time course of glucagon's effect on glycogenolysis and gluconeogenesis in the conscious dog.
    Cherrington AD; Williams PE; Shulman GI; Lacy WW
    Diabetes; 1981 Mar; 30(3):180-7. PubMed ID: 6110598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postmaturity in the rat: glucose metabolism in the fetus and the neonate.
    Le Provost E; Portha B; Cros JC; Picon L
    Pediatr Res; 1980 Jun; 14(6):793-8. PubMed ID: 7402753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Importance of basal glucagon in maintaining hepatic glucose production during a prolonged fast in conscious dogs.
    Hendrick GK; Wasserman DH; Frizzell RT; Williams PE; Lacy DB; Jaspan JB; Cherrington AD
    Am J Physiol; 1992 Sep; 263(3 Pt 1):E541-9. PubMed ID: 1415534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucose metabolism in the newborn rat. Hormonal effects in vivo.
    Snell K; Walker DG
    Biochem J; 1973 Aug; 134(4):899-906. PubMed ID: 4357715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Failure of somatostatin to modify effect of glucagon on carbohydrate metabolism in the dog.
    Cherrington AD; Lacy WW; Williams PE; Steiner KE
    Am J Physiol; 1983 Jun; 244(6):E596-602. PubMed ID: 6134474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.